173 related articles for article (PubMed ID: 38146564)
1. A Rare and Isolated Presentation of Primary Cutaneous Anaplastic Large Cell Lymphoma on the Breast.
Almarzooqi K; Almarzooqi N; Abdelhadi Z
Cureus; 2023 Nov; 15(11):e49387. PubMed ID: 38146564
[TBL] [Abstract][Full Text] [Related]
2. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.
Abdulla FR; Zhang W; Wu X; Honda K; Qin H; Cho H; Querfeld C; Zain J; Rosen ST; Chan WC; Parekh V; Song JY
JID Innov; 2022 Jan; 2(1):100068. PubMed ID: 34977845
[TBL] [Abstract][Full Text] [Related]
4. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL
Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
[TBL] [Abstract][Full Text] [Related]
5. Treatment of primary cutaneous anaplastic large cell lymphoma.
Baik BS; Lee WS; Ji SY; Park KS; Yang WS; Kim SY
Arch Craniofac Surg; 2019 Jun; 20(3):207-211. PubMed ID: 31256561
[TBL] [Abstract][Full Text] [Related]
6. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
7. When Lymphoma Strikes the Pancreas: A Rare Presentation of Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in a Human Immunodeficiency Virus-Positive Patient.
Huang HH; Qing X
J Hematol; 2023 Oct; 12(5):236-242. PubMed ID: 37936974
[TBL] [Abstract][Full Text] [Related]
8. Long-term Follow-up of a Case of Lymphomatoid Papulosis with a Benign Course.
Balić A; Bartolić L; Ilić I; Radoš J
Acta Dermatovenerol Croat; 2018 Oct; 26(3):264-266. PubMed ID: 30390731
[TBL] [Abstract][Full Text] [Related]
9. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
[TBL] [Abstract][Full Text] [Related]
10. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
11. Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile.
Kwatra KS; Paul PAM; Calton N; John JM; Cotelingam JD
South Asian J Cancer; 2017; 6(3):129-131. PubMed ID: 28975123
[TBL] [Abstract][Full Text] [Related]
12. ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas.
Pina-Oviedo S; Ortiz-Hidalgo C; Carballo-Zarate AA; Zarate-Osorno A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572893
[TBL] [Abstract][Full Text] [Related]
13. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
14. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl.
Ju E; Adigun C; Dunphy C; Gold S; Morrell DS
Pediatr Dermatol; 2012; 29(4):498-503. PubMed ID: 21967522
[TBL] [Abstract][Full Text] [Related]
16. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
Gleason L; Afifi L; Banner L; Talasila S; Joffe D; Bhatti S; Alpdogan O; Porcu P; Nikbakht N
Mol Clin Oncol; 2024 May; 20(5):35. PubMed ID: 38596625
[TBL] [Abstract][Full Text] [Related]
17. Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma: A Rare Association With Large Plaque Parapsoriasis.
Manole I; Butacu AI; Negulet IE; Valcoci MC; Tiplica GS
Cureus; 2020 Oct; 12(10):e11228. PubMed ID: 33269156
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A; Soma L
Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]